Table I.
SNPs | eQTL p-value |
Cytokine Affected | Affected Sample | cQTL p-value |
Candidemia Susceptibility p-value |
Risk Allele Frequency | Candidemia Susceptibility Odds Ratio |
---|---|---|---|---|---|---|---|
rs12282890 | 6.22E-06 | IL-1β | Candida blastospores, (HK), WB, 48 hr | 0.0122 | NS | n/a | n/a |
rs12282890 | 6.22E-06 | IL-17 | C. albicans blastospores, PBMC, 7 days | 0.0471 | NS | n/a | n/a |
rs1429553 | 1.11E-03 | IL-6 | C. albicans hyphae, PBMC, 24 hr | 0.0018 | NS | n/a | n/a |
rs7932712 | 0.0014 | none | n/a | NS | 0.0215 | C, 0.71 | 1.49 |
List of CD82 SNPs in the 500 FG cohort for Candida-induced cytokines and candidemia susceptibility in whole blood (WB) or peripheral blood mononuclear cell (PBMC) samples. Two polymorphisms were associated with changes to IL-1β, IL-17, and IL-6 cytokines. The SNP rs7932712 was associated with an elevated susceptibility to develop candidemia. eQTL, SNPs correlated with expression level of CD82; cQTL, SNPs correlated with cytokine levels; NS, SNPs were tested but are not associated with the phenotype.